|
|
||||||||
1 Thoracic Oncology, and Depts of 2 Respiratory Physiology, and 5 Cardiothoracic Surgery, Papworth Hospital, and 3 Medical Research Council (UK) Biostatistics Unit, and 4 Dept of Radiology and Nuclear Medicine, Addenbrooke's Hospital, Cambridge, UK
CORRESPONDENCE: T. Win, Thoracic Oncology Unit, Papworth Hospital, Papworth Everard, Cambridge, CB3 8RE, UK. Fax: 44 1480364331. E-mail: thida.win@papworth.nhs.uk
Keywords: Lung carcinoma, lung function, lung function tests, surgical resection
Received: June 28, 2004
Accepted November 26, 2004
The British Thoracic Society and American College of Chest Physician guidelines outline criteria for investigating patients for lung cancer surgery. However, the guidelines are based on relatively old studies. Therefore, the relationship between pulmonary function test results and surgical outcome were studied prospectively in a large cohort of lung cancer patients.
From January 2001 to December 2003, 110 patients underwent surgery for lung cancer. All underwent full lung function testing in order to predict post-operative lung function.
The hospital mortality rate was 3% and major complication rate 22%. There was poor overall outcome in 13%. Mean pre-operative lung function values were: forced expiratory volume in one second (FEV1) 2.0 L (79.4% of the predicted value), and carbon monoxide diffusing capacity of the lung (DL,CO) 73.6% pred. The mean post-operative lung function values were: FEV1 1.4 L (55.6% pred), and DL,CO 51.3% pred. All lung function values were better predictors of poor surgical outcome when expressed as a percentage of the predicted value. Using a threshold of pre-operative FEV1 of 47% pred resulted in the most useful positive and negative predictive probabilities, 0.90 and 0.67, respectively.
Lung function values expressed as a percentage of the predicted value are more useful predictors of post-operative outcome than absolute values. The threshold of predicted forced expiratory volume in one second for surgical intervention could be lower (4550% pred) than is currently accepted without increased mortality.
This article has been cited by other articles:
![]() |
R. P. Young, R. J. Hopkins, B. A. Hay, M. J. Epton, P. N. Black, and G. D. Gamble Lung cancer gene associated with COPD: triple whammy or possible confounding effect? Eur. Respir. J., November 1, 2008; 32(5): 1158 - 1164. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. K. Bernstein and S. Deshpande Preoperative Evaluation for Thoracic Surgery Seminars in Cardiothoracic and Vascular Anesthesia, June 1, 2008; 12(2): 109 - 121. [Abstract] [PDF] |
||||
![]() |
G. L. Colice, S. Shafazand, J. P. Griffin, R. Keenan, and C. T. Bolliger Physiologic Evaluation of the Patient With Lung Cancer Being Considered for Resectional Surgery: ACCP Evidenced-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 161S - 177S. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bauer, J.-G. Hentz, X. Ducrocq, M. Nicolas, M. Oswald-Mammosser, A. Steib, and J.-P. Dupeyron Lung Function After Lobectomy: A Randomized, Double-Blinded Trial Comparing Thoracic Epidural Ropivacaine/Sufentanil and Intravenous Morphine for Patient-Controlled Analgesia Anesth. Analg., July 1, 2007; 105(1): 238 - 244. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. Mineo, O. Schillaci, E. Pompeo, D. Mineo, and G. Simonetti Usefulness of Lung Perfusion Scintigraphy Before Lung Cancer Resection in Patients with Ventilatory Obstruction Ann. Thorac. Surg., November 1, 2006; 82(5): 1828 - 1834. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Garzon, C. S.H. Ng, A. D.L. Sihoe, A. V. Manlulu, R. H.L. Wong, T. W. Lee, and A. P.C. Yim Video-Assisted Thoracic Surgery Pulmonary Resection for Lung Cancer in Patients with Poor Lung Function Ann. Thorac. Surg., June 1, 2006; 81(6): 1996 - 2003. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |